Biotech · Private company
Xentria, Inc.
Track this companyFree. Adds Xentria, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- XTMAB-16Phase 2 · Pulmonary SarcoidosisClinicalTrials.gov · fetched Nov 12, 2026
- XTMAB-16 2 mg/kgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- XTMAB-16 4mg/kgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary SarcoidosisPHASE2 · COMPLETED · started Mar 1, 2024ClinicalTrials.gov NCT06169397 · fetched Nov 12, 2026
- Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary ManifestationsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 10, 2023ClinicalTrials.gov NCT05890729 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Jun 25, 2021ClinicalTrials.gov NCT04971395 · fetched Nov 12, 2026